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Histopathological characteristics of metastasizing squamous cell carcinoma of the skin
and lips
Aims: The reported incidence of metastasis from squ-
amous cell carcinoma (SCC) of the skin and lip varies
between 0.5% and 16%. Clinical and histopathological
criteria have been proposed to identify tumours that
may have an increased risk of metastasis. The aim of
this study was to deﬁne such high-risk tumours,
especially since the incidence of SCC of the skin is
increasing.
Methods and results: Histopathological features of meta-
stasized skin and lip tumours and a matched group of
non-metastasizing tumours were reassessed. Charac-
teristics studied were: tumour width, excision mar-
gins, histological subtype, Clark level, Breslow depth,
tumour differentiation, inﬂammation, perineural and
angio-invasive growth, ulceration and desmoplasia.
Data were statistically analysed separately for skin and
labial lesions. Desmoplasia, Clark level, Breslow depth,
maximum diameter, angio-invasion, grading, perineu-
ral invasion, plasma cells and eosinophilic inﬂamma-
tory response proved to be statistically signiﬁcantly
related to metastasis of skin tumours. Breslow depth,
plasma cells and grading appeared to be statistically
signiﬁcantly related to metastasis of SCC of the lips.
Conclusions: A typical metastatic SCC showed: a
tumour width of at least 15 mm, a vertical tumour
thickness (¼ Breslow) of at least 2 mm, less differen-
tiation, presence of desmoplasia and an inﬂammatory
response with eosinophils and plasma cells.
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Introduction
Squamous cell carcinoma (SCC) of the skin is the
second most frequent malignant tumour in the head
and neck region and is associated with an appreciable
rate of metastasis (0.5–16%).
1–10 The registration of
SCCs is inadequate; many patients are treated in
private practice and excised tumours sometimes have
no histological veriﬁcation. The potential for metastatic
disease with SCC of the skin is often under-emphasized,
especially among dermatologists who frequently han-
dle malignant degeneration of actinic lesions.
The potential for metastasis may also be underesti-
mated because patients presenting with tumour in a
lymph node may not associate such metastasis with a
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itisunpredictablewhether aSCCwillmetastasizeornot.
The clinical classiﬁcation of SCC, as established
primarily by the International Union against Cancer
(UICC), does not allow an optimal estimation of
metastatic risk. The TNM (Tumor Node Metastases)
staging system has proved satisfactory for many
malignant tumours, but is not reliable for assessment
of the metastatic potential of skin SCC; clinical experi-
ence shows that even small carcinomas can metasta-
size. The question therefore arises which additional
prognostic factors,
11 such as anatomical site, histolog-
ical features, aetiology, host immunosuppression and
prior treatment, are indicative of the metastatic risk of
a tumour.
12–14
Petter, Haustein and Breuniger,
12–17 found that
tumour size, Clark level, Breslow depth, mitotic index,
ulceration, blood vessel invasion, lymphatic invasion,
tumour-associated tissue eosinophilia and desmoplasia
are related to metastasis. In our study we investigated
what proportion of SCCs metastasize and if histopatho-
logical features can be identiﬁed to predict metastatic
potential.
The prevalence of metastasis was determined for two
locations of the tumour, the lips and other locations
within the skin, because SCC of the lip shows a higher
risk of metastasis.
8
Materials and methods
The PALGA registry system (a national registry system
of all histopathological specimens in the Netherlands)
was used to obtain the records of all registered SCCs of
the skin and metastases in the University Hospital of
Maastricht in the period between 1982 and 2002.
All available tissue sections of the tumours that
metastasized were compared with a control group
of non-metastasizing tumours. Both groups were
reassessed by both dermatologist and dermatopatho-
logist for histopathological characteristics. We matched
tumours for the following factors: gender, primary or
recurrent lesion, use of immunosuppression, location of
the lesion, prior therapy and the length of the follow-
up period. Recurrent lesions were deﬁned as lesions
with the same histology that showed complete clinical
response to treatment, but reappeared at the same site.
Information regarding immune status was obtained
from electronic patient ﬁles. The follow-up period was
deﬁned as the time from the diagnosis to the beginning
of our study (January 2003). To diminish the possibil-
ity of missing metastases in the matched group, we
used matched cases with a follow-up of at least 3 years
because SCC tumours usually metastasize after 3 years
or longer. The primary outcome variable of this study
was metastasis, scored as 0 (absent) or 1 (present).
The tumour characteristics assumed to be related to
metastasis based on previous studies were: tumour
width, excision margins, histological subtype, Clark’s
depth, Breslow depth, tumour differentiation, inﬂam-
matory cell invasion (lymphocytes, eosinophils, neu-
trophils, histiocytes, plasma cells), perineural and
angio-invasion, ulceration and desmoplasia.
The tumour width was taken from the histology
reports and patient ﬁles. In most cases the exact
tumour size was recorded in these reports. In some
cases, however, no size was mentioned. In those cases
the maximum size of the skin excision was used
corrected for the tumour-free margin. When there was
no reporting of margins, we assumed that there was a
clinical tumour-free margin of 5 mm, which is the
clinical standard in our hospital. Excision margins
were stated free with wide margins, i.e. >2 mm (1),
involved (2) or free with narrow margins (3). Brack-
eted numbers represent the score given to the respect-
ive parameters. The SCC was subtyped as being a
regular horn forming SCC (1) or one of the less
common forms of SCC, being: acantholytic SCC (2),
spindle cell SCC (3), basosquamous SCC (4) desmo-
plastic SCC (5) or verrucous SCC (6). Clark’s depth was
scored according to the anatomical invasiveness, based
on Clark’s scoring system. The most invasive point was
measured.
Breslow depth was measured from the granular layer
of the skin to the deepest point with an accuracy
of 0.1 mm. Tumour differentiation was classiﬁed into
well (1), moderately (2) or poorly (3) differentiated.
Grading was based on cellular pleomorphism and
(de)squamation.
The inﬂammation (lymphocytes, histiocytes, eos-
inophils, neutrophils, plasma cells) in the tissue was
subtyped and scored dichotomously. No or limited
invasion with inﬂammatory cells was scored as 0,
moderate and major invasion was scored 1.
Perineural invasion and angio-invasion were scored
after staining. Slides were stained for perineural inva-
sion using staining for pankeratins (MNF-116) and
S100 antigen. Angio-invasion was identiﬁed using
immunohistochemistry for CD31. Invasion was recor-
ded as either absent (0) or present (1). Ulceration and
desmoplastic stromal reaction were graded using the
same two-point scale as for inﬂammatory cell inﬁltrate.
statistics
Data were analysed separately for skin and lip
tumours. In both analyses, having or not having a
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If metric variables (or variates) appeared to be non-
normally distributed and were regarded as an out-
come variable, an attempt was made to normalize
their distribution by transforming them by logarithms
(based on 10).
Student’s t-test was also performed. Tumour charac-
teristics considered to be relevant for prediction of the
prevalence of metastasis consisted of a set of two
continuous variables and 13 discrete classiﬁcations.
First, log-likelihood v
2 and odds ratios [with 95%
conﬁdence intervals (CIs)] were calculated for each
separate risk (or protective) variable or factor. For this
purpose continuous variables were also dichotomized
on their median value. Next, a multivariate logistic
regression analysis was carried out using the backward
elimination log-likelihood v
2 technique with all relevant
variables and factors. The result of this search technique
for the best ﬁtting model is presented as a reduced
logistic regression model containing only statistically
signiﬁcant predictors. Net-effect odds ratios (and 95%
CIs) of this eventual model are presented in Table 1.
A P-value <0.05 was considered to be statistically
signiﬁcant. All data analysis was performed with SPSS-
pc version 12.0 (SPSS Inc., Chicago, IL, USA).
Results
During the period 1982–2002, 915 SCCs of the skin
(n ¼ 852) and lip (n ¼ 63) in 580 patients were found;
68 of these 915 tumours (7.4%) in 580 patients
(11.72%) did metastasize. The prevalence of metastasis
for lip SCC alone was 20.6% (13 ⁄ 63) and for skin
tumours 6.5% (55 ⁄ 852). For both tumour locations
27% patients were women and 73% were men. The
mean age among women was 79 years and 82 years
for men. The mean follow-up was 5.7 years (0.25–
21 years). In the total group three patients were
immunosuppressed and seven had a recurrent lesion.
Of the 68 metastases, 13 cases (19.1%) were on the lip
and 37 (54.4%) were in the head and neck region.
Nineteen (28%) of the metastases were located in the
locoregional lymph nodes, mostly ipsilateral.
skin tumours (n ¼ 110)
In the group of skin tumours 55 cases were compared
with 55 controls. In the metastatic group of skin SCCs
desmoplasia, Clark level (Figure 1), Breslow depth and
maximum diameter, angio-invasion, grading, perineu-
ral invasion (Figure 2), plasma cells and eosinophils
(Figure 3) proved to be statistically signiﬁcantly related
to metastasis. Table 1a lists the results of the histo-
pathological characteristics of the skin tumour which
metastasized.
In the multivariate analysis of skin SCC metastasis
the eventual model found contains three risk fac-
tors and one protecting factor. In order of statistical
importance the risk factors comprise: the maximum
diameter of the tumour (in mm), having or not having
tumour desmoplasia (Figures 5 and 6) and the reclas-
siﬁed, trichotomous Clark index. Finally, the only
protective factor was found to be having or not having
a lymphocytic inﬁltrate. Grade of differentiation was
found to be the only remaining risk factor that was
almost statistically signiﬁcant (overall P-value of back-
ward elimination v
2 was 0.083).
lip tumours (n ¼ 63)
In the group of lip tumours 13 cases were combined
with 50 controls. In the group of lip SCCs, Breslow,
plasma cells (Figure 4) and grading appeared to be
statistically signiﬁcant prognostic factors for metastasis.
Table 1b lists the histopathological characteristics of
the tumours of the lips. Of the tumours with Breslow
thickness > 4.8 mm, 53% metastasized compared with
0% of SCCs <4.8 mm. Breslow thickness was a
statistically signiﬁcant prognostic factor for metastasis
[odds ratio (OR) ¼3.71, P < 0.001].
The multivariate analysis of lip SCC with metastasis
showed that only one risk factor turned out to have a
signiﬁcant OR for metastasis, namely having or not
having an inﬁltrate of plasma cells.
Discussion
SCC of the skin is a potentially lethal form of skin
cancer, responsible for 20% of all cutaneous malig-
nancies. The incidence of metastasis from skin and lip
SCCs varies between 0.5% and 16%.
18 Some patients
are known to die of local invasion of the tumour or
metastases and these cases are difﬁcult to detect in
retrospective studies. Clinical and histopathological
criteria have been proposed to identify tumours that
may have an increased risk of metastasis.
Patients with metastatic disease have a poor prog-
nosis, with 10-year survival rates of <20%. It is
therefore important to deﬁne high-risk tumours and
treat these tumours aggressively with large excision
margins and ⁄ or adjuvant radiotherapy, especially
since the incidence of SCC of the skin is increasing.
In our study we examined histopathological features
that might predict the metastatic potential of SCCs
of the skin and lip. To gain a better appreciation of
histopathological parameters important in the develop-
258 P J F Quaedvlieg et al.
  2006 The Authors. Journal compilation   2006 Blackwell Publishing Ltd, Histopathology, 49, 256–264.Table 1a. Skin histopathological characteristics of the skin related to metastasis (n ¼ 110)
n %META’S X
2L P OR Lower Upper n
Grading 1 47 30 20.87 <0.001 110
2 41 51 2.48 1.03 5.94
3 22 86 14.93 3.8 58.68
Clark* 1 19 0 51.38 <0.001 – – –
2 11 9 5.57 0.21 149.16
3 28 46 33.95 1.87 617.08
4 27 70 89.48 4.83 1659.05
5 21 86 206.23 9.95 4268.42
RClark 1 + 2 + 3 58 24 32.65 <0.001 – – – 106
4 27 70 7.46 2.69 20.74
5 21 86 18.86 4.83 73.63
Max diam £15 51 24 26.97 <0.001 9.25 3.74 22.85 101
>15 50 74
Breslow £2.85 45 13 42.90 <0.001 25.28 8.17 78.20 89
>2.85 44 80
Perineural invasion 0 64 45 14.97 <0.001 8.851 2.41 32.57 89
12 5 8 8
Angio-invasion 0 62 42 22.89 <0.001 17.31 3.76 79.62 89
12 7 9 3
Lymphocytes 0 95 53 6.98 0.01 0.16 0.34 0.78 108
11 3 1 5
Histiocytes 0 76 46 0.45 0.50 1.33 0.58 3.04 108
13 2 5 3
Eosinophils 0 82 42 6.2 0.013 3.18 1.24 8.15 108
12 6 6 9
Neutrophils 0 102 49 0.57 0.45 0.52 0.91 2.97 108
16 3 3
Plasma cells 0 75 39 9.00 0.003 3.65 1.52 8.76 108
13 3 7 0
Inﬁltration 0 96 52 5.84 0.16 0.18 0.04 0.89 108
11 2 1 7
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study we matched for the following factors: gender,
primary or recurrent lesion, immunosuppression, loca-
tion of the lesion, the therapy used and the length of
follow-up. We realize that our study is retrospective
and that for some characteristics relatively large
numbers of values were missing. The group of patients
with metastasis was small, so the statistical analysis
of these results met with some difﬁculties. Future
prospective studies should therefore be very large to
interpret outcomes.
The study found that 68 of 915 tumours in 580
patients had metastasized. The rate of metastases was
therefore 11.7% for the patients and 7.4% for the
tumours. Males seem to have a higher incidence
of metatastatic disease compared with women, even
taking into account the larger numbers of SCCs in
men.
19 This was also found in our study. A review
of the literature from 1940 until 1992 revealed that
recurrent SCC has a signiﬁcantly higher metastatic rate
than primary SCC. For recurrent tumours there was a
metastatic rate of 25% for skin SCC, a rate of 45% for
ear SCC and a rate of >30% for the lip. We found three
(4.4%) recurrent lesions in the metastatic group.
11
The effect of immunosuppression has been studied
extensively, mostly because of the growing number
of transplant recipients. It is not certain whether the
higher number of metastatic lesions in an immuno-
suppressed patient is due to the more aggressive nature
of every single SCC or the presence of multiple typical
SCCs often seen in transplantation patients.
20–23 In the
group with metastasis studied, only one (1.5%) of the
patients was immunosuppressed.
Tumour width, deﬁned as the maximum diameter of
the lesion, is an important prognostic factor for the
metastatic potential of SCC. Signiﬁcant correlation
of tumour size with metastasis has been found in
a number of reports.
8,11,12,15,16,18,24 We also found
tumour width to be signiﬁcantly associated with
metastatic potential. A size of ‡20 mm triples the risk
of metastasis compared with lesions <20 mm.
11,15,25
In a German study, 78% of metastasizing tumours were
>20mm.
13
In our study 50% of the metastasized tumours were
at least 15 mm in diameter. However, this does not
mean smaller tumours are not capable of metastasis.
In one study none of 14 metastasizing periauricular
tumours was larger than 2 cm.
12–13 This suggests that
other prognostic factors should also be taken into
account. Excision margins might also be important.
Our results show that margins of <2 mm are
insufﬁcient. This is in line with another study, which
showed a cumulative tumour clearance of only 78%
with 2-mm margins.
25 This is far less than the 96%
with 4-mm margins. Margins of 2 mm seemed to be
insufﬁcient in wider and less differentiated tumours.
25
The depth of tumour invasion can be expressed
according to Clark, or according to Breslow. Clark’s
classiﬁcation is more widely used in the setting of SCC
of the skin. As in our study, earlier studies point to the
worse prognosis of deeper tumours.
11,12,15,16,26–28
Some studies have found metastases only when there
was invasion of subcutaneous tissue. This was not
the case in our population, although the tumours were
at least Clark II. Breuniger and colleagues found
a metastatic rate of <1% when only the dermis
Table 1a. (Continued)
n %META’S X
2L P OR Lower Upper n
Ulceration 0 87 43 2.83 0.09 2.48 0.84 7.31 104
11 76 5
Desmoplasia 0 66 21 47.09 <0.001 29.71 8.99 98.19 102
13 68 9
Margins 1 85 53 3.76 0.15 – – – 109
2 15 40 0.59 0.19 1.81
3 9 22 0.25 0.05 1.29
*½ added to frequencies.
OR + odds ratio.
log likelihood v
2.
%META’S, %metastasis.
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subcutaneous fat and a rate of >12% when deeper
tissue was invaded. Measuring Breslow depth (vertical
tumour thickness) is a more time-consuming way of
expressing tumour depth. In our study all metastatic
‘pure’ skin tumours were >2.85 mm thick. SCC of the
Table 1b. Histopathological characteristics of the lips related to metastasis (n ¼ 63)
n %META’S X
2L P OR Lower Upper n
Grading 1 27 7 6.97 0.03
2 27 22 3.57 0.65 19.59 62
3 8 50 12.50 1.69 92.25
Max. diameter £15 28 18 0.64 0.42 1.70 0.46 6.21 54
>15 26 27
Breslow £4.8 19 0 16.89 <0.001 3.71* 0.77 6.65 37
>4.8 18 53
Perineural invasion 0 45 18 2.13 0.15 3.08 0.70 13.52 55
11 0 4 0
Angio-invasion 0 53 21 0.80 0.37 3.82 0.22 66.02 55
12 5 0
Lymphocytes 0 56 21 0.01 0.94 0.92 0.09 8.98 61
15 2 0
Histiocytes 0 37 19 0.32 0.57 1.43 0.42 4.92 61
12 4 2 5
Eosinophils 0 54 22 0.25 0.62 0.58 0.64 5.33 61
17 1 4
Neutrophils 0 57 21 0.33 0.86 1.25 0.12 13.12 61
14 2 5
Plasma cells 0 51 14 8.95 0.01 9.43 2.12 42.07 61
11 0 6 0
Inﬁltrationj 0 50 20 0.27 0.60 1.5 0.34 6.70 61
11 1 2 7
Ulceration 0 44 18 2.16 0.14 2.8 0.73 10.90 57
11 3 3 9
Desmoplasia 0 35 23 0.01 0.94 1.06 0.29 3.78 56
12 1 2 1
*½ added to frequencies.
OR + odds ratio.
log likelihood v
2.
%META’S, %metastasis.
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Figure 2. Perineural invasion.
Figure 3. Plasma cells and eosinophils.
Figure 4. Plasma cells.
Figure 5. Desmoplasia.
Figure 6. Desmoplasia.
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all.
12,15–17,24,26,28–30
In our study, measurements of tumour differen-
tiation were based on cellular polymorphism and
(de)squamation. Both are signiﬁcantly associated with
metastatic potential according to Petter and Hau-
stein.
12 Like most studies, we did not differentiate the
histological grading further with regard to these
separate factors. A signiﬁcant relationship between
differentiation and metastases has often been found,
although some studies could not establish such a
relationship.
1,14,19,24,29,31,32 Our results conﬁrm it
and endorse the importance of tumour differentiation.
Ulceration, histiocytic inﬂammation and neutrophilic
inﬂammation were not related to metastasis in our
patients. Some previous studies are in agreement
with our own
8,18,24,30,33,34 but other studies have
reported that these factors are related to metasta-
ses.
11,12,16,32
The incidence of perineural invasion in SCC is
reported to be 3.7%.
11 Lesions with perineural invasion
have a signiﬁcantly higher risk of metastatic disease.
Metastases in neurotropic skin SCC occur in 5.9–
34.8%, depending on treatment regimen. In our study
perineural invasion also seems to be an important
factor in skin metastasis. Lip SCC has an even worse
prognosis when neurotropism is present, with reported
metastatic rates of 60–80%. We did not conﬁrm this in
our study.
Angio-invasion is, to our knowledge, a factor less
extensively investigated.
30 Our results have shown a
statistically signiﬁcant relationship with metastasis in
this respect.
Desmoplastic SCC has been deﬁned as a SCC with
ﬁne, diffusely inﬁltrating branches of tumour cells at
the periphery, surrounded by a strong ﬁbrotic stro-
mal reaction. Desmoplastic SCC frequently metasta-
sizes.
12,16,23 We did ﬁnd many tumours that matched
the criteria for desmoplastic SCC. However, we saw at
least a little desmoplasia in every metastasizing
tumour. Based on the results of our study, desmoplasia
might therefore be regarded as an important factor in
SCC of the skin.
Conclusion
A typical metastatic SCC showed: a tumour width of
at least 15 mm, a vertical tumour thickness of at least
2 mm and at least Clark II, less differentiation, presence
of desmoplasia and invasion with eosinophils and
plasma cells.
The next step will be to establish a prospective study
with a follow-up of at least 3 years, in order to establish
a risk proﬁle of SCC of the skin, based on histopatho-
logical tumour characteristics.
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